Endocrine Society member Whitney Goldner, MD, has been named the new head of the Division of Endocrinology, Metabolism, and Diabetes in the Department of Medicine at the University of Colorado School of Medicine, Anschutz Medical Campus in Aurora.
Currently, Goldner is professor of internal medicine, Division of Diabetes, Endocrinology and Metabolism at the University of Nebraska Medical Center. She also serves as medical director of the Thyroid and Endocrine Tumor Program at the Fred and Pamela Buffett Cancer Center at Nebraska Medicine.
Her duties with the Endocrine Society are numerous and include serving on the Clinical Endocrinology Update Committee (later serving as chair); the Clinical Affairs Core Committee; two terms on the Board of Directors (vice president, physician-in-practice and at large member); editorial board member and associate editor for The Journal of Clinical Endocrinology & Metabolism; chair of the Clinical Endocrine Education Committee; and many more.
Goldner earned her MD at the University of Nebraska Medical Center. Her internship and residency at the University of Utah was followed by an endocrine fellowship at the University of Iowa Hospital and Clinics. Following her fellowship training, she was recruited to the University of Nebraska where she eventually became a full professor.
As a physician scientist, Goldner’s research interests center on thyroid cancer. She has been funded by numerous entities including the National Institutes of Health (NIH), Department of Health and Human Services, industry and foundations. She is particularly interested in understanding the impact of environmental exposures such as pesticides on cancer risk. She is a member of the PATCAM Advisory Group, an entity that advises investigators with NIH funding on modeling the risk of thyroid malignancies.
She will begin her new position July 1, 2024.